AI assistant
LIVIUM LTD — Director's Dealing 2022
Dec 15, 2022
65239_rns_2022-12-15_496786e8-8d07-40c4-ab0b-b5b8f398638d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11
| Name of entity Lithium Australia Limited | |
|---|---|
| ABN 29 126 129 413 | |
| We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the | |
| director for thepurposes of section 205G of the Corporations Act. | |
| Name of Director George Bauk |
|
| Date of last notice 3 November 2021 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| isclosed in thispart. | |
|---|---|
| Direct or indirect interest | Indirect 1, Indirect 2 |
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Indirect 1 Totode Pty Ltd of which George Bauk is a beneficiary Indirect 2 Totode Pty Ltd of which George Bauk is a beneficiary |
| Date of change | 16 December 2022 |
| No. of securities held prior to change | Indirect 1 632,382 Ordinary Shares Indirect 2 3,160,719 Ordinary Shares 1,000,000 Performance Rights expiring 7 May 2023 |
| Class | Performance Rights expiring 30 November 2026 |
| Number acquired | 12,250,000 |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
$0.0201 per performance right (non-cash) based on the valuation as detailed in the notice of Annual General Meeting |
| No. of securities held after change | Indirect 1 632,382 Ordinary Shares Indirect 2 3,160,719 Ordinary Shares 1,000,000 Performance Rights expiring 7 May 2023 12,250,000 Performance Rights expiring 30 November 2026 |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
Nature of change Issue of performance rights as approved by Example: on-market trade, off-market trade, exercise of options, issue of shareholders at the Annual General Meeting held securities under dividend reinvestment plan, participation in buy-back on 29 November 2022 (Resolution 7(a)).
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| sclosed in thispart. | |
|---|---|
| Detail of contract | N/A |
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| **Date of change ** | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
| **Interest after change ** | N/A |
Part 3 –[+] Closed period
| art 3 –+Closedperiod | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period whereprior written clearance was required? |
No |
| If so, wasprior written clearanceprovided to allow the trade toproceed during thisperiod? | N/A |
| Ifprior written clearance wasprovided, on what date was thisprovided? | N/A |
16 December 2022
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 2